BRIEF-Bayer, J&J to study Xarelto for pulmonary embolism, DVT in cancer patients
May 28, 2015 at 08:35 AM EDT
* And partner J&J say to initiate study to explore xarelto in prevention and treatment of pulmonary embolism and deep vein thrombosis in cancer patients Further company coverage:
